APOE and Alzheimer disease: Participants with aMCI due to AD were significantly older (p = .001), carried the APOE ε4 allele at significantly higher rates (p = .009), and scored significantly worse on BNT-30 (p = .017) compared to participants with MCI due to FTLD.